Pfizer/BioNTech strike South Africa COVID-19 manufacturing deal with Biovac
Pfizer Inc and BioNTech SE on Wednesday said they had struck a deal for South Africa's Biovac Institute to process and distribute over 100 million doses a year of their Covid-19 vaccine for the African Union beginning in 2022.
Technical transfer, on-site development and equipment installation activities will begin immediately, they said. Biovac, a public-private partnership focused on vaccine production, will receive Covid-19 vaccine drug substance made in plants in Europe, and will begin so-called fill-finish operations, the last stage of drug manufacturing and packaging, in 2022.
Pfizer announced the partnership ahead of a speech by Chief Executive Albert Bourla at a World Trade Organization (WTO) Summit.
WTO members have been in talks for months on waiving drug firms' intellectual property (IP) rights for Covid-19 vaccines. Most developing countries support the waiver but several wealthy countries remain strongly opposed, saying it will deter research that allowed Covid-19 vaccines to be produced so quickly.
In his prepared remarks, Bourla made a plea for the group to maintain the current IP rules.
"Weakening IP rules will only discourage the type of unprecedented innovation which brought vaccines forward in record time and make it harder for companies to collaborate going forward," Bourla said.
Last month, the World Health Organization said it was setting up a hub, or training facility, in South Africa to give companies there the know-how and licenses to produce Covid-19 vaccines. Biovac was one of the initial participants in the hub.
Biovac has partnered with Pfizer since 2015 to manufacture and distribute its Prevenar 13 pneumonia vaccine.
Comments
Research Reports
Latest Multimedia
Latest News
Showroom
John Thompson, the leader in energy and environmental solutions through value engineering and innovation, provides the following: design, engineer,...
VISIT SHOWROOM
Press Office
Announcements
What's On
Subscribe to improve your user experience...
Option 1 (equivalent of R125 a month):
Receive a weekly copy of Creamer Media's Engineering News & Mining Weekly magazine
(print copy for those in South Africa and e-magazine for those outside of South Africa)
Receive daily email newsletters
Access to full search results
Access archive of magazine back copies
Access to Projects in Progress
Access to ONE Research Report of your choice in PDF format
Option 2 (equivalent of R375 a month):
All benefits from Option 1
PLUS
Access to Creamer Media's Research Channel Africa for ALL Research Reports, in PDF format, on various industrial and mining sectors
including Electricity; Water; Energy Transition; Hydrogen; Roads, Rail and Ports; Coal; Gold; Platinum; Battery Metals; etc.
Already a subscriber?
Forgotten your password?
Receive weekly copy of Creamer Media's Engineering News & Mining Weekly magazine (print copy for those in South Africa and e-magazine for those outside of South Africa)
➕
Recieve daily email newsletters
➕
Access to full search results
➕
Access archive of magazine back copies
➕
Access to Projects in Progress
➕
Access to ONE Research Report of your choice in PDF format
RESEARCH CHANNEL AFRICA
R4500 (equivalent of R375 a month)
SUBSCRIBEAll benefits from Option 1
➕
Access to Creamer Media's Research Channel Africa for ALL Research Reports on various industrial and mining sectors, in PDF format, including on:
Electricity
➕
Water
➕
Energy Transition
➕
Hydrogen
➕
Roads, Rail and Ports
➕
Coal
➕
Gold
➕
Platinum
➕
Battery Metals
➕
etc.
Receive all benefits from Option 1 or Option 2 delivered to numerous people at your company
➕
Multiple User names and Passwords for simultaneous log-ins
➕
Intranet integration access to all in your organisation
